{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:18:12Z","timestamp":1787339892013,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154655","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:55:48Z","timestamp":1687812948000},"page":"154655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-4746","authenticated-orcid":false,"given":"Yasir","family":"Alshareefy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosheene Jeya","family":"Prekash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154655_bib1","unstructured":"National Cancer Institute D SRPCancer Statistics BranchSurveillance, Epidemiology, and End Results (SEER) Program 2015."},{"key":"10.1016\/j.prp.2023.154655_bib2","first-page":"168","article-title":"Differential diagnosis of tumors and tumor- like lesions of liver in infancy and childhood","volume":"91","author":"Edmondson","year":"1956","journal-title":"AMA J. Dis. Child"},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S","article-title":"Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features","volume":"46","author":"Craig","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154655_bib4","unstructured":"Bosman, F.T. (2010). World Health Organization International Agency for Research on Cancer. WHO classification of tumours of the digestive system."},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2008.12.009","article-title":"Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy","volume":"35","author":"Maniaci","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2023.154655_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/BF02093600","article-title":"Fibrolamellar hepatocellular carcinoma. case reports and a review of the literature","volume":"41","author":"Saab","year":"1996","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.prp.2023.154655_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0046-8177(88)80261-2","article-title":"Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature","volume":"19","author":"Berman","year":"1988","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/dc.10088","article-title":"Hepatocellular carcinoma-fibrolamellar variant: cytopathology of an unusual case","volume":"26","author":"Kunz","year":"2002","journal-title":"Diagn. Cytopathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1542\/peds.82.3.379","article-title":"Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver","volume":"82","author":"McCloskey","year":"1988","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.prp.2023.154655_bib10","first-page":"1797","article-title":"Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma","volume":"83","author":"Agarwal","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<136::AID-MPO8>3.0.CO;2-L","article-title":"A childhood fibrolamellar hepatocellular carcinoma with increased aromatase activity and a near triploid karyotype","volume":"28","author":"Hany","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.24811","article-title":"Fibrolamellar hepatocellular carcinoma presenting with budd-chiari syndrome, right atrial thrombus, and pulmonary emboli","volume":"55","author":"Asrani","year":"2012","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.prp.2023.154655_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000200995","article-title":"Budd-chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma","volume":"53","author":"Lamberts","year":"1992","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jjco\/hyh050","article-title":"A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female","volume":"34","author":"Kanai","year":"2004","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2023.154655_bib15","first-page":"809","article-title":"Fibrolamellar hepatocellular carcinoma in a Thai man who presented with hypoglycemia: case report and review of literature","volume":"83","author":"Tangkijvanich","year":"2000","journal-title":"J. Med. Assoc. Thail."},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib16","first-page":"47","article-title":"Fibrolamellar hepatic carcinoma with a presentation similar to that of septic pregnancy: a case report","volume":"47","author":"Dahan","year":"2002","journal-title":"J. Reprod. Med. Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.prp.2023.154655_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/01913129409016302","article-title":"Fibrolamellar hepatic tumor with neurosecretory features and systemic deposition of AA amyloid","volume":"18","author":"Lloreta","year":"1994","journal-title":"Ultrastruct. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0720-048X(91)90028-T","article-title":"Fibrolamellar hepatocellular carcinoma presenting with obstructive jaundice. a report of two cases","volume":"13","author":"Soyer","year":"1991","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/00313028809085212","article-title":"Fibrolamellar carcinoma as a cause of bile duct obstruction","volume":"20","author":"Eckstein","year":"1988","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.30.2.243","article-title":"Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis","volume":"30","author":"Snook","year":"1989","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib21","first-page":"159","article-title":"Fibrolamellar carcinoma of the liver-an unusual presentation","volume":"39","author":"Vaideeswar","year":"1993","journal-title":"J. Postgrad. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0720-048X(99)00137-0","article-title":"Fibrolamellar carcinoma: an unusual clinico-radiological presentation","volume":"32","author":"Gupta","year":"1999","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/j.1536-4801.1994.tb11472.x","article-title":"Fibrolamellar hepatocellular carcinoma: report of a case mimicking a liver abscess","volume":"19","author":"Debray","year":"1994","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/088800101750238586","article-title":"Fibrolamellar hepatocellular carcinoma with skeletal metastases","volume":"18","author":"Tezer","year":"2001","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154655_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPH.0b013e3181984f7f","article-title":"Fibrolamellar carcinoma presenting as a pancreatic mass: case report and review of the literature","volume":"31","author":"Thirabanjasak","year":"2009","journal-title":"J. Pediatr. Hematol. \/Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0256-4947.76409","article-title":"Cold agglutinin disease in fibrolamellar hepatocellular carcinoma: a rare association with a rare cancer variant","volume":"31","author":"Al-Matham","year":"2011","journal-title":"Ann. Saudi Med."},{"issue":"6174","key":"10.1016\/j.prp.2023.154655_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1249484","article-title":"Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma","volume":"343","author":"Honeyman","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18632\/oncotarget.2712","article-title":"The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients","volume":"6","author":"Darcy","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5858\/2004-128-222-FHCOYA","article-title":"Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis","volume":"128","author":"Terracciano","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"9","key":"10.1016\/j.prp.2023.154655_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0046-8177(94)90015-9","article-title":"DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis","volume":"25","author":"Orsatti","year":"1994","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/modpathol.2008.32","article-title":"Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas","volume":"21","author":"Vivekanandan","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154655_bib32","doi-asserted-by":"crossref","unstructured":"Tr\u00e4nkenschuh W., Puls F., Christgen M., et al. Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS ONE. 2010;5(10)e13688.","DOI":"10.1371\/journal.pone.0013688"},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00000658-199410000-00007","article-title":"Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma","volume":"220","author":"Ehrenfried","year":"1994","journal-title":"Ann. Surg."},{"issue":"24","key":"10.1016\/j.prp.2023.154655_bib34","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1158\/1078-0432.CCR-04-0941","article-title":"mTOR and P70 S6 kinase expression in primary liver neoplasms","volume":"10","author":"Sahin","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2023.154655_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/modpathol.3800665","article-title":"EGFR is phosphorylated at Ty845 in hepatocellular carcinoma","volume":"19","author":"Kannangai","year":"2006","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.humpath.2005.12.009","article-title":"Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma","volume":"37","author":"Buckley","year":"2006","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.humpath.2008.08.003","article-title":"Anterior gradient-2 is overexpressed by fibrolamellar carcinomas","volume":"40","author":"Vivekanandan","year":"2009","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2023.154655_bib38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0046-8177(88)80261-2","article-title":"Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature","volume":"19","author":"Berman","year":"1988","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1148\/radiology.213.2.r99nv31352","article-title":"Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases","volume":"213","author":"Ichikawa","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.prp.2023.154655_bib40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S","article-title":"Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features","volume":"46","author":"Craig","year":"1980","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/radiology.217.1.r00se46145","article-title":"Fibrolamellar hepatocellular carcinoma: Pre- and posttherapy evaluation with CT and MR imaging","volume":"217","author":"Ichikawa","year":"2000","journal-title":"Radiology"},{"issue":"supplement 1","key":"10.1016\/j.prp.2023.154655_bib42","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1432-2277.2000.tb02071.x","article-title":"Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma","volume":"13","author":"El-Gazzaz","year":"2000","journal-title":"Transpl. Int."},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.21703","article-title":"Outcome of patients with fibrolamellar hepatocellular carcinoma","volume":"106","author":"Stipa","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510260412","article-title":"Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation","volume":"26","author":"Pinna","year":"1997","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.prp.2023.154655_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/modpathol.3800449","article-title":"Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis","volume":"18","author":"Kakar","year":"2005","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ajcp\/74.3.254","article-title":"Ground-glass cells in hepatocellular carcinoma","volume":"74","author":"Stromeyer","year":"1980","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/ajcp\/81.4.521","article-title":"Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change","volume":"81","author":"Vecchio","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1097-0142(19830101)51:1<97::AID-CNCR2820510120>3.0.CO;2-1","article-title":"Copper and copper-binding protein in fibrolamellar liver cell carcinoma","volume":"51","author":"Lefkowitch","year":"1983","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/1097-0142(19880315)61:6<1155::AID-CNCR2820610616>3.0.CO;2-6","article-title":"Copper and copper-binding protein in liver tumors","volume":"61","author":"Guigui","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154655_bib50","unstructured":"Liu S., Chan K.W., Wang B., Qiao L.,. Fibrolamellar hepatocellular carcinomaAm J Gastroenterol 2009 1041026172624quiz 262519638962."},{"issue":"9","key":"10.1016\/j.prp.2023.154655_bib52","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/modpathol.2010.105","article-title":"Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation","volume":"23","author":"Ward","year":"2010","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1309\/TT0R7KAL32228E99","article-title":"Primary liver carcinoma arising in people younger than 30 years","volume":"124","author":"Klein","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.1990.tb00679.x","article-title":"Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver","volume":"17","author":"Van Eyken","year":"1990","journal-title":"Histopathology"},{"issue":"01","key":"10.1016\/j.prp.2023.154655_bib55","doi-asserted-by":"crossref","first-page":"061","DOI":"10.1055\/s-0031-1272835","article-title":"Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors","volume":"31","author":"Ward","year":"2011","journal-title":"Semin. Liver Dis."},{"issue":"6345","key":"10.1016\/j.prp.2023.154655_bib56","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bmj.285.6345.840","article-title":"High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma","volume":"285","author":"Paradinas","year":"1982","journal-title":"Br. Med J. (Clin. Res Ed. )"},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0676.1997.tb00798.x","article-title":"Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta","volume":"17","author":"Orsatti","year":"2008","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2010.207","article-title":"Fibrolamellar carcinomas are positive for CD68","volume":"24","author":"Ross","year":"2011","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1309\/TT0R7KAL32228E99","article-title":"Primary liver carcinoma arising in people younger than 30 years","volume":"124","author":"Klein","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiology.157.3.2997835","article-title":"Fibrolamellar hepatocellular carcinoma","volume":"157","author":"Friedman","year":"1985","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2214\/AJR.13.11117","article-title":"Imaging features of fibrolamellar hepatocellular carcinoma","volume":"202","author":"Ganeshan","year":"2014","journal-title":"Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1148\/radiol.2232010801","article-title":"Radiologists\u2019 performance in the diagnosis of liver tumors with central scars by using specific CT criteria","volume":"223","author":"Blachar","year":"2002","journal-title":"Radiology"},{"issue":"8376","key":"10.1016\/j.prp.2023.154655_bib63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0140-6736(84)90934-6","article-title":"Neurotensin secretion by fibrolamellar carcinoma of the liver","volume":"323","author":"Collier","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2023.154655_bib64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1091-255X(97)80055-8","article-title":"Aggressive surgical management of fibrolamellar hepatocellular carcinoma","volume":"1","author":"Hemming","year":"1997","journal-title":"J. Gas. - trointest Surg."},{"issue":"5","key":"10.1016\/j.prp.2023.154655_bib65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0936-6555(05)80724-1","article-title":"Fibrolamellar hepatocellular carcinoma responsive to platinum-based combination chemotherapy","volume":"8","author":"Bower","year":"1996","journal-title":"Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1200\/JCO.2003.10.103","article-title":"Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma","volume":"21","author":"Patt","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4240\/wjgs.v6.i6.107","article-title":"Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma","volume":"6","author":"Fonseca","year":"2014","journal-title":"World J. Gastrointest. Surg."},{"issue":"6","key":"10.1016\/j.prp.2023.154655_bib68","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/MJT.0b013e3182840fa6","article-title":"A case of fibrolamellar cancer with a palliative response and minor radiographic regression with erlotinib and bevacizumab combination therapy","volume":"21","author":"Fakih","year":"2014","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000338242","article-title":"Prolonged complete response after GEMOX chemotherapy in a patient with advanced fibrolamellar hepatocellular carcinoma","volume":"5","author":"Gras","year":"2012","journal-title":"Case Rep. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/modpathol.2014.78","article-title":"mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma","volume":"28","author":"Riehle","year":"2015","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154655_bib71","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.humpath.2005.12.009","article-title":"Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma","volume":"37","author":"Buckley","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154655_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/JHC.S75153","article-title":"Fibrolamellar hepatocellular carcinoma: current clinical perspectives","author":"Pawlik","year":"2015","journal-title":"J. Hepatocell. Carcinoma Publ. Online"},{"issue":"1","key":"10.1016\/j.prp.2023.154655_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00000421-199902000-00006","article-title":"Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history","volume":"22","author":"Epstein","year":"1999","journal-title":"Am. J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2023.154655_bib74","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/1097-0142(19831015)52:8<1516::AID-CNCR2820520831>3.0.CO;2-N","article-title":"Hepatocellular carcinoma in young people","volume":"52","author":"Farhi","year":"1983","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154655_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/lt.500050201","article-title":"Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review","volume":"5","author":"Houben","year":"1999","journal-title":"Liver Transplant. Surg."},{"issue":"3","key":"10.1016\/j.prp.2023.154655_bib76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/hep.20096","article-title":"Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population\u2010based study","volume":"39","author":"El\u2010Serag","year":"2004","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.prp.2023.154655_bib77","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.11292","article-title":"Fibrolamellar hepatocellular carcinoma in children and adolescents","volume":"97","author":"Katzenstein","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154655_bib78","first-page":"5","article-title":"Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma","author":"Moreno-Luna","year":"2005","journal-title":"BMC Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:03:29Z","timestamp":1774411409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":77,"alternative-id":["S0344033823003552"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154655","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154655"}}